Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

U.S. Pharmaceuticals: spending on research and development 1980-2018

Pharmaceutical research and development expenditure in the U.S. from 1980 to 2018 (in billion U.S. dollars)

by Matej Mikulic, last edited Jul 31, 2019
U.S. Pharmaceuticals: spending on research and development 1980-2018 This statistic depicts the research and development expenditure of PhRMA members from 1980 to 2018. In 2000, the expenditure of PhRMA members within the U.S. pharmaceutical industry on research and development amounted to 26 billion U.S. dollars.
Show more

Pharmaceutical research and development expenditure in the U.S. from 1980 to 2018 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Canadian pharmaceutical industry"
  • Global positioning
The most important statistics
  • Key figures
  • Regional comparison
  • Generics
  • Products and prices
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.